Clinical Trials Logo

Dietary Exposure clinical trials

View clinical trials related to Dietary Exposure.

Filter by:

NCT ID: NCT04235348 Completed - Dietary Exposure Clinical Trials

The Impact of Red Meat and Whole-grains Intake on the Colonic Mucosal Barrier

Start date: June 1, 2017
Phase:
Study type: Observational

This study evaluates the impact of red meat and whole-grain intake on the colonic mucosal barrier and the dietary impact of these groups on the induced low-grade inflammation

NCT ID: NCT04173117 Terminated - Dietary Exposure Clinical Trials

Feasibility of Low Energy Diet in HFpEF and Type 2 Diabetes

ALLEVIATE
Start date: February 28, 2020
Phase: N/A
Study type: Interventional

Open, Single arm intervention, feasibility study

NCT ID: NCT04103294 Completed - Dietary Exposure Clinical Trials

Measuring Cowpea Consumption in Young Children and Pregnant Women in Ghana

Start date: July 25, 2019
Phase: N/A
Study type: Interventional

Current dietary assessment methods rely on self-report food intake such as food frequency questionnaires, 24-hr dietary recall, or diet diaries, and the prevalence of misreporting with these tools is estimated at 30-88%.A reliable and convenient way to measure the quantity of cowpea consumed by an individual. The hope is to identify a novel set of dietary biomarkers that will measure cowpea consumption, be free from participant recall bias, and serve to quantify legume intake. A total of 40 subjects, 20 children (9-21 months) and 20 pregnant women (>18 yr) will consume 3 distinct daily intake dosages of cooked cowpeas with the daily intake increased every 5 days. Urine samples will be collected 3 times during each 5-day period and blood spots will be collected during a washout period and at the end of the final 5-day period. Urine samples will undergo metabolite detection via ultra-performance liquid chromatography tandem mass spectrometry in positive and negative ion mode. Peaks are quantified using area-under-the-curve (AUC) and each metabolite is quantified in terms of its median-scaled relative abundance for the metabolite across the entire data set. A repeated measures 2-way ANOVA will be used to compare cowpea metabolite abundances over time and with respect to variation in an individual baseline levels.

NCT ID: NCT03998800 Completed - Dietary Exposure Clinical Trials

Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

The objective of this trial is to determine the effects of dietary supplementation with the amino acids, L-arginine and L-citrulline, on endurance performance and mitochondrial respiration in healthy men compared to supplementation with L-arginine alone and a placebo supplement.

NCT ID: NCT03683654 Completed - Dietary Exposure Clinical Trials

Discovery of Novel Biomarkers of Dietary Exposure in the EPIC Calibration Study

Start date: April 26, 2012
Phase:
Study type: Observational

This proposal aims at identifying new biomarkers of dietary exposure using metabolomic approaches. This project is based on the European Prospective Investigation on Cancer and Nutrition (EPIC) Calibration Study and more particularly upon a subset of 494 men and women from 4 European countries (Germany, Greece, Italy and France). Urine and blood samples are analyzed by untargeted metabolomics.

NCT ID: NCT03562988 Completed - Dietary Exposure Clinical Trials

Bioequivalence Study on Vitamin C in Healthy Adults

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The objective of this exploratory pharmacokinetic research study is to demonstrate that both caplets and gummies provide an effective dose of ascorbic acid in healthy adults.

NCT ID: NCT02838732 Completed - Dietary Exposure Clinical Trials

Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity

Start date: May 18, 2016
Phase: N/A
Study type: Interventional

In this project, the investigators aim to explore the impact of dietary L-carnitine supplementation on the TMAO production capacity of gut microbiota.